Nexalis Therapeutics Limited (ASX:NX1)

Australia · Delayed Price · Currency is AUD

0.0240

+0.0010 (4.35%)

At close: Apr 20, 2026

Revenue by Segment

Financials in millions AUD. Fiscal year is January - December.

Millions AUD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Development of Medical Technologies			1.20M	24.80K	181.74K	22.13K	132.98K
Development of Medical Technologies Growth			4755.02%	-86.35%	721.35%	-83.36%	-64.76%
Total			1.20M	24.80K	181.74K	22.13K	132.98K
Total Growth			4755.02%	-86.35%	721.35%	-83.36%	-64.76%

Revenue by Geography

Financials in millions AUD. Fiscal year is January - December.

Millions AUD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Australia			-	24.80K	167.30K	12.56K	-
Australia Growth			-	-85.18%	1232.33%	-	-
Germany			-	-	-	-	46.60K
Germany Growth			-	-	-	-	-86.52%
Total			-	24.80K	167.30K	12.56K	46.60K
Total Growth			-	-85.18%	1232.33%	-73.05%	-86.52%

Source: S&P Global Market Intelligence.